Salmeterol inhibition of mediator release from human lung mast cells by β-adrenoceptor-dependent and independent mechanisms

British Journal of Pharmacology

Volumn 123, Issue 5, 1998, Pages 1009-1015

  Chong, Lee K ^a   Cooper, Elizabeth ^a   Vardey, Christopher J ^b   Peachell, Peter T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

adrenoceptors; Human lung mast cells; Mediator release; Salmeterol

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; HISTAMINE; ISOPRENALINE; PROPRANOLOL; SALBUTAMOL; SALMETEROL;

ARTICLE; DRUG ANTAGONISM; DRUG POTENCY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; HISTAMINE RELEASE; HUMANS; ISOPROTERENOL; LUNG; MAST CELLS; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0031883632     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701703     Document Type: Article

References (33)

1. ALI, H. & PEARCE, F.L. (1985). Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions, 16, 138 - 140.
2. ANDERSON, G.P., LINDEN, A. & RABE, K.F. (1994). Why are long-acting beta-adrenoceptor agonists long-acting? Eur. Respir. J., 7, 569 - 578.
3. ASSEM, E.S.K. & SCHILD, H.O. (1969). Beta-adrenergic receptors concerned with the anaphylactic mechanism. Int. Arch. Allergy Appl. Immunol., 45, 62 - 69.
4. BAKER, A.J. & FULLER, R.W. (1990). Anti-inflammatory effect of salmeterol on human alveolar macrophages. Am. Rev. Resp. Dis., 141, A394.
5. 2 adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmacol., 104, 665 - 671.
6. BUTCHERS, P.R., SKIDMORE, I.F., VARDEY, C.J. & WHEELDON, A. (1980). Characterisation of the receptor mediating the antianaphylactic activities of β-adrenoceptor agonists in human lung tissue in vitro. Br. J. Pharmacol., 71, 663 - 667.
7. BUTCHERS, P.R., VARDEY, C.J. & JOHNSON, M. (1991). Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br. J. Pharmacol., 104, 672 - 676.
8. CHONG, L.K., MORICE, A.H., YEO, W.W., SCHLEIMER, R.P. & PEACHELL, P.T. (1995). Functional desensitization of β agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol., 13, 540 - 546.
9. CHURCH, M.K. & HIROL, J. (1987). Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by antiallergic drugs and salbutamol. Br. J. Pharmacol., 90, 421 - 429.
10. 2-adrenergic receptor stimulation of adenylyl-cyclase by salmeterol - evidence for quasi-reversible binding to an exosite. Mol. Pharmacol., 49, 182 - 189.
11. COLEMAN, R.A., JOHNSON, M., NIALS, A.T. & VARDEY, C.J. (1996). Exosites: their current status, and their relevance to the duration of action of long-acting β-adrenoceptor agonists. Trends Pharmacol. Sci., 17, 324 - 330.
12. 2-adrenoceptor agonist salmeterol in guinea pig trachea. Br. J. Pharmacol., 104, 1057-1061.
13. ENNIS, M. (1991). Current techniques of histamine determination. Automated fluorometric assays. Handbook Exp. Pharmacol., 97, 31 - 38.
14. FULLER, R.W., O'MALLEY, G., BAKER, A.J. & MACDERMOT, J. (1988). Human alveolar macrophage activation: Inhibition by forskolin but not beta-adrenoceptor stimulation or phospho-diesterase inhibition. Pulmon. Pharmacol., 1, 101 - 106.
15. GILBERT, H.S. & ORNSTEIN, L. (1975). Basophil counting with a new staining method using Alcian Blue. Blood, 46, 279 - 282.
16. 2-adrenoceptor agonists on anti-IgE-induced contraction- and smooth muscle reactivity in human airways. Br. J. Pharmacol., 114, 935 - 940.
17. ISHIZAKA, T., CONRAD, D.H., SCHULMAN, E.S., STERK, A.R. & ISHIZAKA, K. (1983). Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. J. Immunol., 130, 2357 - 2362.
18. JOHNSON, M., BUTCHERS, P.R., COLEMAN, R.A., NIALS, A.T., STRONG, P., SUMNER, M.J., VARDEY, C.J. & WHELAN, C.J. (1993). The pharmacology of salmeterol. Life Sci., 52, 2131 - 2143.
19. 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human. Int. Arch. Allergy Immunol., 105, 177 - 180.
20. 2-adrenoceptor agonist mediating cyclicAMP accumulation in a neuronal cell line. Br. J. Pharmacol., 110, 619 - 626.
21. NIALS, A.T., COLEMAN, A.R., JOHNSON, M., MAGNUSSEN, H., RABE, K.F. & VARDEY, C.J. (1993). Effects of adrenoceptor agonists in human bronchial smooth muscle. Br. J. Pharmacol., 110, 1112 - 1116.
22. NIALS, A.T., COLEMAN, A.R., JOHNSON, M. & VARDEY, C.J. (1994). The β-adrenoceptor pharmacology of the enantiomers of salmeterol. Am. Rev. Resp. Dis., 149, A481.
23. NIALS, A.T., COLEMAN, A.R., JOHNSON, M. & VARDEY, C.J. (1997). The duration of action of non-β-adrenoceptor mediated responses to salmeterol. Br. J. Pharmacol., 120, 961 - 967.
24. NIALS, A.T., SUMNER, M.J., JOHNSON, M. & COLEMAN, A.R. (1993). Investigations into factors determining the duration of action of the β-adrenoceptor agonist, salmeterol. Br. J. Pharmacol., 108, 507 - 515.
25. ORANGE, R.P., AUSTEN, W.G. & AUSTEN, K.F. (1971). Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′5′-adenosine monophosphate. J. Exp. Med., 134, 136 - 148.
26. PEACHELL, P.T., MACGLASHAN, D.W., LICHTENSTEIN, L.M. & SCHLEIMER, R.P. (1988). Regulation of human basophil and lung mast cell function by cAMP. J. Immunol., 140, 571 - 579.
27. SCHULMAN, E.S., MACGLASHAN, D.W., PETERS, S.P., SCHLEIMER, R.P., NEWBALL, H.H. & LICHTENSTEIN, L.M. (1982). Human lung mast cells: purification and characterisation. J. Immunol., 129, 2662 - 2667.
28. SIRAGANIAN, R.P. (1974). An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem., 57, 283 - 287.
29. TATTERSFIELD, A.E. (1992). Bronchodilators: new developments. Br. Med. Bull. 48, 51 - 64.
30. TATTERSFIELD, A.E. (1993). Clinical pharmacology of long-acting β-receptor agonists. Life Sci., 52, 2161 - 2169.
31. 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax, 43, 674 - 678.
32. UNDEM, B.J., PEACHELL, P.T. & LICHTENSTEIN, L.M. (1988). Isoproterenol-induced inhibition of IgE-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. J. Pharmacol. exp. Ther., 247, 209 - 217.
33. YUKAWA, T., UKENA, D., CHANEZ, P., DENT, G., CHUNG, K.F. & BARNES, P.J. (1990). Beta-adrenergic receptors on eosinophils: Binding and functional studies. Am. Rev. Resp. Dis., 141, 1446 - 1452.